−2.4 PLN
−5.59 M PLN
0.00 PLN
About URTESTE
Sector
Industry
CEO
Grzegorz Stefanski
Website
Headquarters
Gdansk
Founded
2019
ISIN
PLURTST00010
FIGI
BBG0136J6WT6
Urteste SA specializes in the development of technology that allows the detection of cancers at early stages of their development. Its technology helps to detect cancers by measuring the activity of the enzymes in urine and also develops diagnostic tests for more than ten of the most common cancers. The company was founded on April 24, 2019 and is headquartered in Gdansk, Poland.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of URT is 84.0 PLN — it has decreased by −0.94% in the past 24 hours. Watch URTESTE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GPW exchange URTESTE stocks are traded under the ticker URT.
URT stock has risen by 7.14% compared to the previous week, the month change is a −2.33% fall, over the last year URTESTE has showed a −14.29% decrease.
URT stock is 0.00% volatile and has beta coefficient of 0.15. Track URTESTE stock price on the chart and check out the list of the most volatile stocks — is URTESTE there?
Yes, you can track URTESTE financials in yearly and quarterly reports right on TradingView.
URT net income for the last quarter is −374.00 K PLN, while the quarter before that showed −554.00 K PLN of net income which accounts for 32.49% change. Track more URTESTE financial stats to get the full picture.
No, URT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 3, 2025, the company has 66 employees. See our rating of the largest employees — is URTESTE on this list?
Like other stocks, URT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade URTESTE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So URTESTE technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating URTESTE stock shows the strong sell signal. See more of URTESTE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.